US Broker Ratings

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Volatility and Revenue Challenges

Zhengye Biotechnology Holding Limited (ZYBT), a key player in China’s healthcare sector focusing on veterinary vaccines, has been navigating a challenging financial landscape. With a market capitalization of $54.5 million..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Unveiling a 242% Potential Upside for Investors

Senseonics Holdings, Inc. (NASDAQ: SENS) is capturing the attention of the investment community with its innovative approach to diabetes management. Headquartered in Germantown, Maryland, this healthcare company specializes in developing..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: A Biotech Gem with Nearly 68% Upside Potential

Investors seeking opportunities in the biotechnology sector may find Fulcrum Therapeutics, Inc. (NASDAQ: FULC) an intriguing prospect. With a current market capitalization of approximately $746.12 million, this clinical-stage biopharmaceutical company..

Mereo BioPharma Group (MREO): Analyst Ratings Hint at a Staggering 792.54% Upside Potential

The biopharmaceutical landscape is one that constantly evolves, with companies racing to develop groundbreaking therapies that address both common and rare conditions. Among these innovators is Mereo BioPharma Group plc..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Evaluating the Growth Potential in a Promising Biotechnology Sector

Cidara Therapeutics, Inc. (NASDAQ: CDTX) is making waves in the healthcare sector, specifically within the biotechnology industry. The company has a market capitalization of $6.95 billion and is headquartered in..

Exxon Mobil Corporation (XOM) – Investor Outlook: Navigating Growth Amidst a 9.32% Potential Upside

Exxon Mobil Corporation (XOM), a titan in the Energy sector, stands as a formidable player in the Oil & Gas Integrated industry. With a robust market capitalization of $513.04 billion,..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 13% Upside Potential in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, particularly in diagnostics and research, is capturing investor attention with its potential upside of 13.31%. This Florida-headquartered company, with..

Integra LifeSciences Holdings C (IART) Stock Analysis: Unpacking a 22.92% Potential Upside in the Medical Devices Sector

For investors eyeing opportunities in the healthcare sector, Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents an intriguing proposition. As a key player in the medical devices industry, Integra offers a..

Novavax, Inc. (NVAX) Stock Analysis: Navigating the 87% Potential Upside Amidst Biotech Volatility

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, continues to attract attention with its innovative vaccine solutions. With a market capitalization of $1.11 billion, the Gaithersburg, Maryland-based..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 38% Upside Potential in the Biotech Sector

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing significant attention from investors, thanks to its promising clinical-stage developments and a substantial market cap of $2.91 billion. As a player in the..

Dynavax Technologies (DVAX) Investor Outlook: Analyzing a 33% Potential Upside in the Biopharma Sector

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the healthcare sector, is making waves with its promising vaccine developments and a notable 33.38% potential upside, according to analyst ratings...

Harrow, Inc. (HROW) Stock Analysis: A Promising 39% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may want to consider Harrow, Inc. (NASDAQ: HROW), a dynamic player in the ophthalmic pharmaceutical industry. Currently priced at $50.76, Harrow’s stock has..

The Pennant Group, Inc. (PNTG): Investor Outlook with a 24.30% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG) is capturing the attention of individual investors, particularly those with an interest in the healthcare sector. With its current market position and significant growth..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with a Promising 27.39% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is capturing investor attention with its robust growth trajectory and compelling potential upside of 27.39%, as indicated by current analyst ratings. As a leading..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is making waves in the biotechnology sector with its focus on developing therapies for autoimmune diseases. With a market capitalization of $2.09 billion, this Canadian..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Complex Market with a 7.47% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG), a key player in the healthcare sector, specializes in health information services, offering innovative solutions for analyzing biological systems. Headquartered in Pleasanton, California, this life..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 10.73% Potential Upside Amidst Robust Revenue Growth

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is capturing attention in the biotechnology sector with its promising developments in dermatological disease treatments. Headquartered in Westlake Village, California, this biopharmaceutical company is advancing..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Prescription for Growth with 9.75% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN), a prominent player in the healthcare sector, is gaining investor attention with its specialized services in medical care facilities across the United States. With..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 49.59% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is worth a close look by investors seeking opportunities in the medical care facilities industry. With a market capitalization..

Neogen Corporation (NEOG) Stock Analysis: Evaluating the 13% Upside Potential

Neogen Corporation (NASDAQ: NEOG) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Lansing, Michigan, Neogen has carved out a niche..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds